Cyclosporine - USA (March 28, 2018 Events)
As mentioned in earlier post, (click here to view earlier post) The Patent
Trial and Appeal Board (The PTAB) of the United States Patent and Trademark Office
(USPTO) denied to terminate IPRs related to Cyclosporine (Restasis®) filed by The
Saint Regis Mohawk Tribe.
Key
Events of March 28, 2018:
The
Federal Circuit issued a stay of further The PTAB proceedings pending the Tribe’s
sovereign immunity appeal. The appeal challenges the Board’s determination that
the Tribe is not immune from its proceedings as a sovereign entity.
No comments